miVac Quattro from Genevac, High Capacity Biological Sample Concentrator
July 13, 2010
For laboratories looking to concentrate larger numbers of biological samples presented in a range of different formats the miVac Quattro from Genevac is the perfect high capacity sample concentrator. Benchmarked to provide best-of-class performance in all aspects the miVac Quattro provides scientists everything they need to safely and swiftly concentrate or dry their biological samples [...]
Genetix Confirms Bead-based Assay Capabilities for CellReporter System
July 13, 2010
System now provides a multi-application platform for cell- and bead-based assays New Milton, Hampshire – Genetix, a leading provider of solutions for imaging and image analysis, has confirmed that its CellReporter system now supports both cell- and bead-based assay formats. Users can screen cell-by-cell or bead-by-bead within a test population in order to produce accurate, [...]
GE Healthcare Launches New Mag Sepharose™ Beads
July 13, 2010
Simplified handling and high binding capacity for easy magnetic purification and screening of histidine-tagged proteins and antibodies GE Healthcare has launched His Mag Sepharose™ Ni, Protein A Mag Sepharose Xtra, and Protein G Mag Sepharose Xtra magnetic beads. The new magnetic beads provide high binding capacity, for fast separation and high quality results. The highly [...]
Roche Obtains Co-Exclusive License to Develop PCR Assays Detecting Mutations in the PI3K Oncogene
July 13, 2010
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the company has obtained a worldwide co-exclusive license for the biomarker PI3K (phosphoinositide 3-kinase) from QIAGEN to develop real-time and endpoint PCR diagnostic assays. Johns Hopkins University owns the patent for the PI3K biomarker and has previously granted an exclusive license to QIAGEN’s wholly owned subsidiary [...]
July 13, 2010
SAN JOSE, Calif. - Thermo Fisher Scientific Inc., the world leader in serving science, today announced it is outfitting a new research center, AgriBio, the Centre for AgriBioscience located in Victoria, Australia, with a AU$2.5 million of state-of-the-art mass spectrometry (MS) technology. AgriBio, a AU$288 million public private partnership, is a joint initiative of the [...]
Cepheid Files Answer and Counterclaims in Abaxis Patent Suit
July 13, 2010
SUNNYVALE, Calif. - Cepheid (Nasdaq: CPHD) announced today that it has filed an answer and counterclaims in a patent suit brought by Abaxis on June 28, 2010 in the United States District Court for the Northern District of California. In its filing, Cepheid denied Abaxis' allegations of patent infringement, asked the Court to determine it [...]
Ariadne Technology Licensed by Takeda for Evaluation of Potential Antibody Targets
July 13, 2010
Rockville, MD - Ariadne announces that Takeda San Francisco, Takeda's global center for excellence for biologics, has signed an agreement to license Ariadne's Pathway Studio® software. Takeda plans to utilize the software and underlying text-mining algorithms in their discovery program against cancer, inflammatory and metabolic diseases. "We are pleased to add Takeda to our already [...]
July 13, 2010
Vancouver, B.C. - EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave” or “the Company") has announced that it has begun testing a multiple-vial prototype of the Company’s freezeREVTM pharmaceutical dehydration technology designed to dry standard industry serum vials containing vaccines, injectable drugs, analytical enzymes, diagnostic reagents, antibodies and other biological materials. The new multiple-vial prototype has a [...]
Universal Detection Technology Adds Mold Detection Device to Biohazard Detection Product Catalog
July 13, 2010
Device Equips Homeowners and Health Officials With Rapid Detection of Toxic Mold, Detects the Top Three Mold Species: Stachybotrys, Penicillium and Aspergillus LOS ANGELES, CA - Universal Detection Technology (www.udetection.com) (UNDT), a developer of early-warning monitoring technologies to protect people from bioterrorism and other infectious health threats, announced today that it has expanded its product [...]
Malvern: Reverse Engineering Tablets for Counterfeit Investigations
July 13, 2010
Malvern, UK: Chemical imaging specialists at Malvern Instruments are demonstrating how data derived from reverse engineering of pharmaceutical tablets can aid the fight against counterfeit drugs. Using the SyNIRgi near infrared chemical imaging (NIRCI) system they have been able to collect data detailed enough to characterize the formulation and processes used to create individual dosages. [...]
